We have receptors for cannabinoids in the whole body, but the first type (CB1) are very dense in the pain pathways of the brain, spine, and nerves. The second type (CB2) are more important for the immune system but is also involved in inflammation. By gently acting on both pathways, our internal cannabinoids and CBD can balance both pain and inflammation .
Because I never go downtown, I had to stop for a latte at my favorite coffee shop—and a second CBD pick-me-up. By the time I stepped into the crowded Indie Beauty Expo, I felt calm and happy. As an introvert, I usually have a hard time making small talk at events. But post-CBD oil, I felt comfortable enough to chat up a storm with every person I met! Three hours later I dragged myself out of the huge exposition and made it to my meditation class, where I took another dropper of CBD oil. Although I really love meditating, I find it particularly challenging to get into the “zone” after a long day at work. Not so much after taking some CBD—it was easy to calm my mind and tune into my breath, despite how fast-paced my day had been.
CBD works by attaching itself to specific receptors of the body’s own endocannabinoid system. The human body is known to produce cannabinoids of its own, which affect the cannabinoid receptors CB1 and CB2. The CB1 receptors are generally found in the brain, and deal with pain, mood and emotions, movement, appetite, among others. THC acts upon the CB1 receptors. Meanwhile, CB2 receptors are more commonly found throughout the immune system, affecting inflammation and thus pain. CBD is thought to act upon these receptors, by influencing the body to produce its own cannabinoids in order to rebalance itself.
At this time, there does seem to be a growing body of basic pharmacologic data suggesting there may be a role for CBD, especially in the treatment of refractory epilepsy. However, given the lack of well-controlled trials, we must also ask if we are getting ahead of ourselves. Clearly, this is an emotionally and politically charged issue. If this were any other uninvestigated pharmaceutical compound, would we feel as compelled to make the agent widely available before statistically valid class 1 evidence was available for review? Until data from well-designed clinical trials are available and reliable, and standardized CBD products that are produced using GMP are available, caution must be exercised in any consideration of using CBD for the treatment of epilepsy. In the meantime, based upon promising preliminary data, further clinical research should be wholeheartedly pursued.
In addition to all the benefits we’ve already discussed, CBD has been proven to have antioxidant and neuroprotective effects. This means that it helps repair the damage from oxidative stress, which is believed to be a primary cause of diseases like Alzheimer’s, Parkinson’s, ALS — even heart disorders and some forms of cancer. This is a hugely beneficial effect of CBD.
Thanks to research and modern technology the cannabis plant is now being processed in numerous ways to help patients from across the world. Patients are able to benefit of it’s cannabinoids CBD and THC in the form of oils. One of those ways is in the form of CBD Oil. To create CBD oil, solvents, such as CO2 are used to separate the cannabinoids (in the form of oils) from the plant material, creating the highly concentrated product.
Cannabis has always been a popular form of treatment for a variety of medical conditions, but in the 1930’s growing concerns about the dangers of marijuana abuse led to cannabinoids being banned. A century has past and despite all efforts from cannabis enthusiasts through social media channels and online media, cannabis is still classed as a schedule 1 drug.